Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

During the Trading Day
10.69 +0.17 / +1.62%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
10.69 -0.003 / -0.03%
Volume: 210.7K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues60.6M61.3M84.9M121.7M
Cost of Goods Sold16.1M23.4M43.9M45.2M
Depreciation And Amortization2.3M3.2M8.7M33.0M
Operating ExpensesGross Income42.2M34.7M32.3M43.6M
General Expenses23.1M35.6M66.6M66.1M
Other Operating Expenses384.9K0.000.000.00
Research And Development922.4K731.7K4.8M3.9M
Total Operating Expenses41.9M62.2M119.2M144.2M
Non-Operating ExpensesOperating Income18.7M-848.7K-34.3M-22.5M
Extraordinary Credit0.000.0016.6M0.00
Extraordinary Charge-4.8M-600.5K-28.0M-7.3M
Pre-Tax Equity Earnings0.00-240.2K0.000.00
Interest Expense On Debt212.0K168.8K4.2M19.1M
Equity In Earnings-814.4K0.00----
Other Expenses0.000.003.4M-401.0K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income13.8M-1.8M-46.4M-49.0M
Income Taxes-4.6M-374.0K-20.8M-13.7M
Net Income8.3M-1.4M-25.6M-35.3M
Shares To Calculate EPSShares To Calculate EPS24.0M28.1M36.4M37.9M
Shares To Calculate EPS Diluted24.5M28.1M36.4M37.9M
Earnings Per ShareEPS$0.34-$0.05-$0.70-$0.93
EPS Diluted$0.34-$0.05-$0.70-$0.93

To view my watchlist

Not a member yet?

Sign up now for a free account